Determination of P-glycoprotein, MDR-related protein 1, breast cancer resistance protein, and lung-resistance protein expression in leukemic stem cells of acute myeloid leukemia-Reference-Cited by-同舟云学术

Determination of P-glycoprotein, MDR-related protein 1, breast cancer resistance protein, and lung-resistance protein expression in leukemic stem cells of acute myeloid leukemia

Published:2008 Issue:3 Volume:74B Page:163-168
ISSN:1552-4949
Container-title:Cytometry Part B: Clinical Cytometry
language:en
Short-container-title:Cytometry

Author:

de Figueiredo-Pontes Lorena L.,Pintão Maria-Carolina T.,Oliveira Luciana C. O.,Dalmazzo Leandro F. F.,Jácomo Rafael H.,Garcia Aglair B.,Falcão Roberto P.,Rego Eduardo M.

Publisher

Wiley

Subject

Cell Biology,Histology,Pathology and Forensic Medicine

Reference26 articles.

1. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

2. Normal and leukemic hematopoiesis: Are leukemias a stem cell disorder or a reacquisition of stem cell characteristics?

3. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

4. Most Acute Myeloid Leukemia Progenitor Cells With Long-Term Proliferative Ability In Vitro and In Vivo Have the Phenotype CD34+/CD71−/HLA-DR−

5. The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sphingosine-1 phosphate receptor 1 (S1PR1) expression maintains stemness of acute myeloid leukemia stem cells;Cancer Letters;2024-09

2. Immunotherapeutic targeting of surfaceome heterogeneity in AML;Cell Reports;2024-06

3. Can CD34+CD38− lymphoblasts, as likely leukemia stem cells, be a prognostic factor in B-cell precursor acute lymphoblastic leukemia in children?;Frontiers in Pediatrics;2023-08-22

4. Mechanisms of myeloid leukemogenesis: Current perspectives and therapeutic objectives;Blood Reviews;2023-01

5. Harnessing the power of sphingolipids: Prospects for acute myeloid leukemia;Blood Reviews;2022-09